Neogen Earnings
NASDAQ: NEOGHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Neogen earnings summary
In its most recent report on Oct 6, 2026 (Aug/2026), NEOG posted EPS of $-0.05 versus the $0.04 consensus estimate, a negative surprise of 225.0%. Revenue for the quarter was $222.8 million. Quarterly EPS is down 129.4% from the same quarter a year earlier.
Across the last 16 reports, NEOG shares moved an average of 4.9% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
NEOG earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Oct 6, 2026 | $0.04 | $-0.05 | -225.0% | -0.3% |
| Jul 30, 2026 | — | $-0.06 | — | -4.7% |
| Apr 9, 2026 | — | $-0.08 | — | +1.0% |
| Jan 8, 2026 | — | $-0.07 | — | -3.8% |
| Oct 9, 2025 | — | $0.17 | — | -2.6% |
| Jul 30, 2025 | — | $-2.82 | — | +9.0% |
| Apr 9, 2025 | — | $-0.05 | — | -21.3% |
| Jan 15, 2025 | — | $-2.10 | — | -0.8% |
| Oct 10, 2024 | — | $-0.06 | — | +0.5% |
| Jul 30, 2024 | — | $-0.02 | — | +2.6% |
| Apr 9, 2024 | — | $-0.01 | — | -6.2% |
| Jan 9, 2024 | — | $-0.02 | — | -6.5% |
| Oct 10, 2023 | — | $0.01 | — | -2.7% |
| Aug 15, 2023 | — | $-0.02 | — | +1.1% |
| Apr 4, 2023 | — | $0.04 | — | -5.9% |
| Jan 9, 2023 | — | $-0.19 | — | +9.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.